Contract Manufacturing

Lonza utilizes global network for CBD-based drug manufacture

18-Feb-2019 By Maggie Lynch

Lonza and Emerald Health enter an agreement for the large-scale manufacturing of a synthetic derivative of CBD and its oral drug product for the treatment of MS and other CNS diseases.

Sharp mitigates clinical supply overproduction with IRT investment

11-Feb-2019 By Maggie Lynch

Sharp invests $650,000 in its IRT solution to ensure proper supply allocations to support clinical trials and reduce costly overproduction for sponsors.

People on the Move: Outsourcing-Pharma roundup January '19

08-Feb-2019 By Melissa Fassbender

People on the move in January include new CEOs at Lonza, Taconic, MaSTherCell, Pii, and Wasdell, among several other c-suite shakeups and new hires as the industry kicks off the New Year.

Corex opens new clinical trial logistics hub in Ukraine

07-Feb-2019 By Maggie Lynch

Corex will expand to additional markets after opening a new clinical trial logistics hub in Ukraine.

German biotech opens US office to expand its global presence

05-Feb-2019 By Maggie Lynch

Sirion Biotech has opened a US-based office to support local gene therapy research and clinical development with viral vector contract manufacturing.

Sharp’s relocation: ‘Reduces the risks, costs, and supply chain complexity’

04-Feb-2019 By Maggie Lynch

Sharp completes its relocation to its $23m facility in Pennsylvania after making additional investments to integrate services at the site.

Amsbio adds experimental cell lines to CAR-T services lineup

29-Jan-2019 By Maggie Lynch

Amsbio is adding experimental cell lines to its CAR-T cell services to meet an increasing demand for the technology, according to the UK-based provider.

Cognate to collaborate on cell thawing platform to improve product reliability

29-Jan-2019 By Maggie Lynch

The US-based CDMO Cognate intends to collaborate with Astero to provide access to the latter’s cell thawing platform to improve product quality in clinical manufacturing and establish a center of innovation.

Almac expanding personalized cancer vaccine production facilities

21-Jan-2019 By Melissa Fassbender

The Almac Group is doubling its Edinburgh-based footprint to help meet the growing demand for personalized cancer vaccines production.

Biorepository a ‘one-stop’ solution for contract biomanufacturing

21-Jan-2019 By Maggie Lynch

LakePharma opens a GMP biorepository facility to assist clients with biomanufacturing and long-term material storage.

Thousand Oaks secures $45m to expand its CDMO, CMC service offerings

14-Jan-2019 By Maggie Lynch

Thousand Oaks Biopharmaceuticals raised $45m in Series A financing, enabling the company to expand its CDMO and CMC services as well as its capabilities in global biologics development.

Upperton’s new R&D facility receives MHRA approval

08-Jan-2019 By Maggie Lynch

Upperton Pharma’s new and expanded facilities received a positive inspection from MHRA, enabling both research and development and clinical manufacturing at the site.

Rentschler sets up shop in the US with plans to grow CDMO services

07-Jan-2019 By Melissa Fassbender

A “strong client request” has prompted the CDMO Rentschler Biopharma to acquire its first US-based facility, which will provide various development and manufacturing services.

2018 regulatory round-up: Patient safety, data transparency, innovative trial designs

18-Dec-2018 By Melissa Fassbender

Global regulatory agencies had a busy 2018. Here, we take a look back at some of the key developments throughout the year, as the industry navigated challenging politics, pressure to increase transparency, and the rapidly evolving digital health space.

WuXi AppTec expands to create a center of excellence in San Diego

12-Dec-2018 By Melissa Fassbender

The expansion collates WuXi AppTec’s technology platform small molecule capabilities, including screening, discovery biology, pharmacology, and process R&D.